drugset / Trial / NCT00739297

The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)

NCT00739297

Phase 1 Completed 68 enrolled Organon and Co
RandomizedCrossoverDouble-blindTreatment

Summary

This study will test the safety and effectiveness of a range of doses of MK0476 (montelukast) compared to placebo on improved lung function in patients with chronic asthma.

Timeline

Start
2008-07
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 25 ug Inhaled
Subject Montelukast Other / unclassified 50 ug Inhaled
Subject Montelukast Other / unclassified 100 ug Inhaled
Subject Montelukast Other / unclassified 250 ug Inhaled
Subject Montelukast Other / unclassified 500 ug Inhaled
Subject Montelukast Other / unclassified 1000 ug Inhaled

Indications